Eli Lilly’s Covid-19 antibody treatment faces distribution challenges

After Eli Lilly's new IV antibody treatment received emergency FDA approval, the companies say it’s shipping 88,000 doses this week and another 800,000 in December, but that may not be enough as daily infection rates continue to surge.